Clinical Trials Directory

Trials / Completed

CompletedNCT01433952

Pharmacokinetics of Oral Thiamine

Pharmacokinetics of High Dose Oral Thiamine

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
14 (actual)
Sponsor
Baystate Medical Center · Academic / Other
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Accepted

Summary

Elevated levels of thiamine may increase cellular energy metabolism by increasing the activity of pyruvate dehydrogenase complex. This has been hypothesized to have a beneficial affect in patients with several diseases including sepsis, heart failure, and diabetes. There is limited data on the pharmacokinetics of supraphysiologic doses of oral thiamine. The aims of this study are to: * Calculate the plasma and whole blood pharmacokinetics of supraphysiologic doses of oral thiamine in healthy volunteers; * Compare the different thiamine doses on the pharmacokinetic variables using repeated measures ANOVA.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTThiamineVitamin B1
DIETARY_SUPPLEMENTPlaceboPlacebo

Timeline

Start date
2009-06-01
Primary completion
2010-07-01
Completion
2010-07-01
First posted
2011-09-14
Last updated
2011-09-14

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01433952. Inclusion in this directory is not an endorsement.